Evaluation of efficacy and safety of rucinol serum in patients with melasma: a randomized controlled trial

A. Khemis, A. Kaiafa, Catherine Queille‐Roussel, L. Duteil, J.‐P. Ortonne

British Journal of Dermatology · 2007 · 94 citations · 7 references

Abstract

Rucinol serum was shown to have significant efficacy compared with vehicle alone in improving melasma after 3 months of treatment, according to clinical and objective assessments of skin colour.

References

7